Download up to 50 records using a credit card to purchase your current search results.
Purchase your current search resultsIf your search contains more than 50 records, you will receive only the first 50 based on the sorting chosen at the time of purchase. Downloads will contain all fields shown in the individual records, not only those visible on the search results page. If your search is 50 records or higher, a subscription might be a better option.
If your search contains fewer than 50 records, the balance cannot be used for a separate search.
Once you subscribe, you will be able to download your current search results. Downloads will contain all fields shown in the individual records, not only those visible on the search results page.
If the number of records in your search results exceeds the limit of your subscription tier, your download will include the maximum number based on the sorting chosen at the time of the download.
| Top 5 Jurisdictions | Penalty Total (USD) | Number of Records |
|---|---|---|
| United States | $5,869,766,602 | 47 |
| Top 5 Offense Groups | Penalty Total (USD) | Number of Records |
|---|---|---|
| healthcare-related offenses | $5,397,449,298 | 16 |
| government-contracting-related offenses | $368,876,963 | 17 |
| competition-related offenses | $64,000,000 | 4 |
| consumer-protection-related offenses | $24,000,000 | 1 |
| financial offenses | $15,000,000 | 1 |
Click on the company or penalty amount for more information on each case.
| Company | Current Parent Industry | Offense Category | Year | Jurisdiction | Penalty Amount (USD) |
|---|---|---|---|---|---|
| Allergan | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | United States | $2,370,000,000 |
| Abbott Laboratories Inc. | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | United States | $1,500,000,000 |
| Allergan Inc. | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | United States | $600,000,000 |
| Abbott Laboratories | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | United States | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Penalty totals are adjusted to avoid double-counting. $339,148,643 |
| Allergan Finance LLC | pharmaceuticals | off-label or unapproved promotion of medical products | 2021 | United States | $200,000,000 |
| Forest Pharmaceuticals Inc. | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | United States | $164,000,000 |
| Forest Pharmaceuticals Inc. | pharmaceuticals | government contracting fraud | 2010 | United States | $149,000,000 |
| Allergan Ltd. et al. | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | United States | $134,200,000 |
| Abbott Laboratories Inc. | pharmaceuticals | government contracting fraud | 2010 | United States | $126,500,000 |
| Warner Chilcott PLC | pharmaceuticals | off-label or unapproved promotion of medical products | 2015 | United States | $125,000,000 |
| Allergan | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | United States | $78,000,000 |
| Forest Pharmaceuticals Inc. | pharmaceuticals | government contracting fraud | 2010 | United States | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Penalty totals are adjusted to avoid double-counting. $60,000,000 |
| Allergan PLC | pharmaceuticals | off-label or unapproved promotion of medical products | 2023 | United States | $48,666,145 |
| Kos Pharmaceuticals | pharmaceuticals | kickbacks and bribery | 2010 | United States | $41,500,000 |
| Allergan | pharmaceuticals | off-label or unapproved promotion of medical products | 2024 | United States | $38,166,450 |
| Forest Laboratories and Forest Pharmaceuticals | pharmaceuticals | government contracting fraud | 2016 | United States | $38,000,000 |
| Allergan | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | United States | $27,000,000 |
| AbbVie Inc. | pharmaceuticals | consumer protection violation | 2020 | United States | $24,000,000 |
| Abbott Laboratories | pharmaceuticals | anti-competitive practices | 2010 | United States | $22,500,000 |
| Allergan Inc. | pharmaceuticals | investor protection violation | 2017 | United States | $15,000,000 |
| Allergan Inc. | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | United States | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Penalty totals are adjusted to avoid double-counting. $14,750,000 |
| AbbVie Inc. | pharmaceuticals | government contracting fraud | 2019 | United States | $13,747,929 |
| Watson/Schein Pharmaceuticals Inc. | pharmaceuticals | government contracting fraud | 2011 | United States | $11,300,000 |
| Warner Chilcott PLC | pharmaceuticals | government contracting fraud | 2015 | United States | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Penalty totals are adjusted to avoid double-counting. $10,600,000 |
| Allergan Ltd. | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | United States | $7,500,000 |
| Forest Laboratories Inc. | pharmaceuticals | government contracting fraud | 2019 | United States | $7,089,034 |
| Abbott Laboratories | pharmaceuticals | government contracting fraud | 2013 | United States | $6,200,000 |
| Allergan | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | United States | $4,800,000 |
| Kos Pharmaceuticals | pharmaceuticals | kickbacks and bribery | 2010 | United States | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Penalty totals are adjusted to avoid double-counting. $4,454,432 |
| Actavis | pharmaceuticals | government contracting fraud | 2012 | United States | $4,000,000 |
| Allergan Inc. | pharmaceuticals | government contracting fraud | 2018 | United States | $3,500,000 |
| Forest Laboratories | pharmaceuticals | government contracting fraud | 2013 | United States | $3,000,000 |
| Forest Laboratories | pharmaceuticals | government contracting fraud | 2013 | United States | $3,000,000 |
| Forest Laboratories LLC | pharmaceuticals | government contracting fraud | 2016 | United States | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Penalty totals are adjusted to avoid double-counting. $2,500,000 |
| AbbVie Inc. | pharmaceuticals | kickbacks and bribery | 2018 | United States | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Penalty totals are adjusted to avoid double-counting. $1,800,000 |
| Forest Pharmaceuticals Inc. | pharmaceuticals | government contracting fraud | 2012 | United States | $1,750,000 |
| Abbott Laboratories, Inc. | pharmaceuticals | government contracting fraud | 2013 | United States | $1,000,000 |
| Forest Laboratories, Inc. | pharmaceuticals | government contracting fraud | 2012 | United States | $790,000 |
| ABBOTT LABS - N. CHICAGO PLANT | pharmaceuticals | environmental violation | 2011 | United States | $135,756 |
| Actavis Kadian, LLC | pharmaceuticals | healthcare provider violation | 2013 | United States | $116,703 |
| Allergan Plc | pharmaceuticals | labor standards violation | 2016 | United States | $73,999 |
| Allergan Usa Inc | pharmaceuticals | labor standards violation | 2016 | United States | $73,999 |
| Allergan Usa Inc | pharmaceuticals | labor standards violation | 2017 | United States | $64,828 |
| ACTAVIS,INC. | pharmaceuticals | environmental violation | 2015 | United States | $30,800 |
| ABBVIE INC | pharmaceuticals | labor standards violation | 2022 | United States | $27,330 |
| ABBVIE US LLC | pharmaceuticals | labor standards violation | 2021 | United States | $25,973 |
| Allergan Inc | pharmaceuticals | labor standards violation | 2019 | United States | $7,656 |
